LEAFIX MEDICAL LTD

LeaFix developed the only Transcatheter Functional Mitral valve Regurgitation repair solution, performed by an augmentation of the Mitral Valve anterior leaflet. The system is composed of an implant and a delivery system, used for implantation of an

LeaFix develops a minimally invasive implant to repair a leaky mitral valve. Its graft is inserted into the anterior leaflet of the valve increases its surface area, allowing for a more hermetic closure. The company is able to use an extremely thin catheter (FR12), which significantly reduces the complications and risks.

Mitral regurgitation patients.

Boaz Harari - CEO & Co-Founder